Active substance
Fludeoxyglucose f 18
- US FDA 45
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FLUDEOXYGLUCOSE F18 | 20-400mCi/ML | injectable · intravenous | FEINSTEIN | Prescription | 19 Aug 2005 |
| FLUDEOXYGLUCOSE F18 | 20-200mCi/ML | injectable · intravenous | PETNET | Prescription | 25 Feb 2011 |
| FLUDEOXYGLUCOSE F18 | 4-40mCi/ML | injectable · intravenous | UCLA BIOMEDICAL | Prescription | 27 Jun 2013 |
| FLUDEOXYGLUCOSE F18 | 20-240mCi/ML | injectable · intravenous | MCPRF | Prescription | 5 Aug 2013 |
| FLUDEOXYGLUCOSE F18 | 20-150mCi/ML; 20-300mCi/ML | injectable · intravenous | UNIV TX MD ANDERSON | Prescription | 13 Jan 2014 |
| FLUDEOXYGLUCOSE F18 | 20-200mCi/ML | injectable · intravenous | PHARMALOGIC HLDGS | Prescription | 4 Feb 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | WUSM CYCLOTRON | Prescription | 5 Feb 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | UCSF RODIOPHARM | Prescription | 9 May 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | UIHC PET IMAGING | Prescription | 6 Aug 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | MA GENERAL HOSP | Prescription | 25 Sep 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | SOFIE | Prescription | 21 Oct 2014 |
| FLUDEOXYGLUCOSE F18 | 20-200mCi/ML | injectable · intravenous | TRUSTEES UNIV PA | Prescription | 29 Oct 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | CHILDRENS HOSP MI | Prescription | 29 Oct 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | ISOLOGIC INNOVATIVE | Prescription | 29 Oct 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | BRIGHAM WOMENS | Prescription | 30 Oct 2014 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | NCM USA BRONX LLC | Prescription | 7 Jan 2015 |
| FLUDEOXYGLUCOSE F18 | 4-500mCi/ML | injectable · intravenous | NORTHLAND | Prescription | 4 Feb 2015 |
| FLUDEOXYGLUCOSE F18 | 20-500mCi/ML | injectable · intravenous | PRECISION NUCLEAR | Prescription | 7 Apr 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | METHODIST HOSP RES | Prescription | 23 Apr 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | BIOMEDCL RES FDN | Prescription | 1 May 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | BIOMEDCL RES FDN | Prescription | 1 May 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | JUBILANT DRAXIMAGE | Prescription | 23 Jun 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | UNIV UTAH CYCLOTRON | Prescription | 23 Jun 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | UNIV MICHIGAN | Prescription | 17 Jul 2015 |
| FLUDEOXYGLUCOSE F18 | 20-300mCi/ML | injectable · intravenous | SOFIE | Prescription | 31 Aug 2015 |
20 more — full table
Safety signals and safety-related labeling changes
- US FDA 27 Jun 2019 FLUDEOXYGLUCOSE F18 — safety-related labeling change
Labeling sections changed: Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.